Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07527143
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
45 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Key Dates

Start date
Apr 6, 2026
Status verified
Apr 2026
Primary completion
Apr 6, 2027
Completion
Apr 6, 2027

Study Design

Enrollment
25 participants (estimated)

Arms

  • Arm: Observational
    Participants complete a semi-structured interview on study.

Primary Outcome Measure

Acceptability of vaginal fluid collection for a DNA-based early detection endometrial cancer test [ Time Frame: Baseline (30-minute virtual interview) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
855-776-0015
Kelly Gunderson
507-422-1892
Shariska Harrington, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By condition
Endometrial cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies